NZ335183A - The 3-sulphate salt of 17-(alpha,delta) and 17-(beta,delta)-8(9)-dehydroestradiol and use as antioxidants - Google Patents

The 3-sulphate salt of 17-(alpha,delta) and 17-(beta,delta)-8(9)-dehydroestradiol and use as antioxidants

Info

Publication number
NZ335183A
NZ335183A NZ335183A NZ33518397A NZ335183A NZ 335183 A NZ335183 A NZ 335183A NZ 335183 A NZ335183 A NZ 335183A NZ 33518397 A NZ33518397 A NZ 33518397A NZ 335183 A NZ335183 A NZ 335183A
Authority
NZ
New Zealand
Prior art keywords
delta
dehydroestradiol
antioxidants
beta
alpha
Prior art date
Application number
NZ335183A
Inventor
Steven Jay Adelman
Frederick James Bex
Appavu Chandrasekaran
Dorothy Helen Prozialeck
Michael William Winkley
Panolil Raveendranath
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of NZ335183A publication Critical patent/NZ335183A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0062—Estrane derivatives substituted in position 17 alfa not substituted in position 17 beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003

Abstract

This application provides the pharmaceutically acceptable salt of the 3-sulfate ester of 17aD8,9-dehydroestradiol and 17bD8,9-dehydroestradiol. Also included is use of the 3-sulphate as an antioxidant for inhibition or treatment of free radical damage in a mammal.
NZ335183A 1996-10-11 1997-10-09 The 3-sulphate salt of 17-(alpha,delta) and 17-(beta,delta)-8(9)-dehydroestradiol and use as antioxidants NZ335183A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2793696P 1996-10-11 1996-10-11
PCT/US1997/018306 WO1998016544A1 (en) 1996-10-11 1997-10-09 8(9)-dehydroestradiol derivatives

Publications (1)

Publication Number Publication Date
NZ335183A true NZ335183A (en) 2000-09-29

Family

ID=21840614

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ335183A NZ335183A (en) 1996-10-11 1997-10-09 The 3-sulphate salt of 17-(alpha,delta) and 17-(beta,delta)-8(9)-dehydroestradiol and use as antioxidants

Country Status (13)

Country Link
EP (1) EP0934334A1 (en)
JP (1) JP2001502328A (en)
KR (1) KR20000049055A (en)
CN (1) CN1239967A (en)
AR (1) AR014096A1 (en)
AU (1) AU743530B2 (en)
BR (1) BR9712628A (en)
CA (1) CA2268330A1 (en)
HU (1) HUP9903369A3 (en)
IL (1) IL129029A0 (en)
NZ (1) NZ335183A (en)
WO (1) WO1998016544A1 (en)
ZA (1) ZA979069B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002338277B2 (en) * 2001-03-16 2007-11-22 Wyeth Estrogen replacement therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES341947A1 (en) * 1966-06-21 1968-08-01 American Home Prod A procedure for preparing steroid compounds. (Machine-translation by Google Translate, not legally binding)
SU286675A1 (en) * 1969-01-10 1973-08-10 Институт химии природных соединений СССР WAY OF OBTAINING dl-ESTRADIOLAYSS-UNION fi ^ iffiTau - ::: X:.: F-lAfi LIBRARY
FR2136891A1 (en) * 1971-05-07 1972-12-29 Inst Khim Prirodny Racemic estra-3,17 beta-diol prepn - steroid hormones
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
DE4338314C1 (en) * 1993-11-10 1995-03-30 Jenapharm Gmbh Pharmaceutical preparations for the prophylaxis and therapy of radical-mediated cell damage

Also Published As

Publication number Publication date
CN1239967A (en) 1999-12-29
ZA979069B (en) 1999-04-09
IL129029A0 (en) 2000-02-17
KR20000049055A (en) 2000-07-25
WO1998016544A1 (en) 1998-04-23
EP0934334A1 (en) 1999-08-11
BR9712628A (en) 1999-10-26
CA2268330A1 (en) 1998-04-23
HUP9903369A2 (en) 2001-06-28
JP2001502328A (en) 2001-02-20
HUP9903369A3 (en) 2002-02-28
AR014096A1 (en) 2001-02-07
AU5145998A (en) 1998-05-11
AU743530B2 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
IL124459A0 (en) Antagonists of gonadotropin releasing hormone
MX9804850A (en) Antagonists of gonadotropin releasing hormone.
MY106272A (en) Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants.
AU5424898A (en) Concealable protective garment for the groin and method of using the same
HK1011685A1 (en) Compounds having both potent calcium antagonist and antioxidant activity and use thereof as cytoprotective agents
BG102668A (en) Application of ppar-alpha and prar-gamma antagonist for the treatment of syndrome x
AU8154294A (en) Methods of inhibiting atrophy of the skin and vagina
TW366342B (en) The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
AU2685088A (en) Method and apparatus useful for delivering medicinal compositions into the bladder and urinary tract
AU3218197A (en) Natural progesterone for the treatment of side effects of progestins and progesterone analogues
EP0960191A4 (en) Compositions and methods for use of defensin
AU678971B2 (en) Compositions and methods for vaccination against coronaviruses
UA41355C2 (en) Agent for treating neuro-aids
MY121623A (en) Methods of preventing breast cancer.
AUPM771894A0 (en) Method for the treatment of indirect inguinal hernias and related conditions
AU7951591A (en) Methods for treating inflammation and compounds and compositions suitable for use therein
AU3074592A (en) Compositions for delayed treatment of ischemia-related neuronal damage
NZ335183A (en) The 3-sulphate salt of 17-(alpha,delta) and 17-(beta,delta)-8(9)-dehydroestradiol and use as antioxidants
AU3192795A (en) Use of quinone and hydroquinone derivatives for the teatment of cachexia
TW330933B (en) Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
EP0925071A4 (en) Muc-1 as an immunosuppressive therapeutic agent for the treatment of inflammatory and autoimmune conditions
HU0102320D0 (en) Use of steroids for the treatment of menopausal complaints
AU629032B2 (en) Letterpress for transferring and method of transferring by use of the letterpress for transferring
AU2887889A (en) Use of cyclophilin as an anti-inflammatory and immunomodulatory agent
IL130071A0 (en) Use of equilenin as an antioxidant

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)